Article
Medicine, General & Internal
Silva A. Arslanian, Tamara Hannon, Philip Zeitler, Lily C. Chao, Claudia Boucher-Berry, Margarita Barrientos-Perez, Elise Bismuth, Sergio Dib, Jang Ik Cho, David Cox
Summary: The incidence of type 2 diabetes mellitus is increasing among youths. Treatment with dulaglutide at a once-weekly dose of 0.75 mg or 1.5 mg was superior to placebo in improving glycemic control through 26 weeks among youths with type 2 diabetes, without an effect on BMI.
NEW ENGLAND JOURNAL OF MEDICINE
(2022)
Article
Medicine, General & Internal
Silva A. Arslanian, Tamara Hannon, Philip Zeitler, Lily C. Chao, Claudia Boucher-Berry, Margarita Barrientos-Perez, Elise Bismuth, Sergio Dib, Jang Ik Cho, David Cox
Summary: In this 26-week trial, researchers found that once-weekly treatment with dulaglutide has significant efficacy in improving glycemic control among youths with type 2 diabetes.
NEW ENGLAND JOURNAL OF MEDICINE
(2022)
Article
Endocrinology & Metabolism
Ryan D. Russell, Katherine M. Roberts-Thomson, Donghua Hu, Timothy Greenaway, Andrew C. Betik, Lewan Parker, James E. Sharman, Stephen M. Richards, Stephen Rattigan, Dino Premilovac, Glenn D. Wadley, Michelle A. Keske
Summary: Individuals at risk of type 2 diabetes show impaired skeletal muscle microvascular responses postprandially, which may contribute to their increased risk of developing type 2 diabetes.
Review
Cell Biology
Zahra Bahadoran, Parvin Mirmiran, Khosrow Kashfi, Asghar Ghasemi
Summary: Vascular NO resistance is a common state in type 2 diabetes, characterized by impaired vasodilator function of NO in both macro- and microvessels. This resistance is associated with cardiovascular events and death. The mechanisms underlying this resistance include decreased NO production, inactivation, and impaired responsiveness of vascular smooth muscle. Hyperglycemia-induced overproduction of reactive oxygen species and vascular insulin resistance play key roles in this state. Strategies to overcome vascular NO resistance in type 2 diabetes include increasing NO availability, re-sensitizing pathways, and targeting ROS production.
CELL DEATH & DISEASE
(2023)
Review
Health Care Sciences & Services
Mar Sempere-Bigorra, Ivan Julian-Rochina, Omar Cauli
Summary: Diabetic neuropathy presents differences between type 1 and type 2 diabetes patients, with sensory changes being more prominent in type 2 diabetes, while neurological test variations are more common in type 1 diabetes patients. This review highlights the importance of understanding these differences for better clinical management and future research directions in the field.
JOURNAL OF PERSONALIZED MEDICINE
(2021)
Article
Endocrinology & Metabolism
Oana Patricia Zaharia, Dominik Hans Pesta, Pavel Bobrov, Yuliya Kupriyanova, Christian Herder, Yanislava Karusheva, Kalman Bodis, Gidon Josia Boenhof, Johannes Knitza, David Simon, Arnd Kleyer, Jong-Hee Hwang, Karsten Muessig, Dan Ziegler, Volker Burkart, Georg Schett, Michael Roden, Julia Szendroedi
Summary: The study suggests that patients with type 2 diabetes show musculoskeletal impairments and arthritis-related symptoms linked to insulin resistance. Changes in arthritis-related microRNA profiles may be masked by type 2 diabetes.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
(2021)
Article
Endocrinology & Metabolism
Stefano Ciardullo, Alessandro Roberto Dodesini, Giuseppe Lepore, Anna Corsi, Cristiana Scaranna, Gianluca Perseghin, Roberto Trevisan
Summary: A model of insulin sensitivity was developed using clinical and laboratory parameters in patients with type 2 diabetes, and it was found to be associated with all-cause and cardiovascular mortality.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
(2023)
Review
Biochemistry & Molecular Biology
Han-Chow E. Koh, Chao Cao, Bettina Mittendorfer
Summary: Plasma insulin clearance plays an important role in determining plasma insulin concentration and is closely related to excess adiposity, insulin sensitivity, and type 2 diabetes. The lower insulin clearance rate observed in people with obesity is not a compensatory response to insulin resistance, but directly linked to insulin sensitivity. Additionally, postprandial insulin clearance decreases due to increased delivery of insulin to tissues that clear insulin.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Biochemistry & Molecular Biology
Mary D. Adu, Catherine P. Bondonno, Benjamin H. Parmenter, Marc Sim, Raymond J. Davey, Kevin Murray, Simone Radavelli-Bagatini, Dianna J. Magliano, Robin M. Daly, Jonathan E. Shaw, Joshua R. Lewis, Jonathan M. Hodgson, Nicola P. Bondonno
Summary: This study examined the association between flavonoid intake and measures of glucose tolerance and insulin sensitivity in adults, as well as the long-term risk of type 2 diabetes. The results suggest that consuming flavonoid-rich foods may protect against type 2 diabetes by improving glucose tolerance and insulin sensitivity.
Review
Endocrinology & Metabolism
Julia H. Goedecke, Amy E. Mendham
Summary: Sub-Saharan Africa has the highest projected rates of increase in type 2 diabetes, with socioenvironmental and lifestyle factors possibly interacting with genetic factors to alter the pathophysiology. The pathophysiology of type 2 diabetes in Black Africans is different from that in their European counterparts. However, current understanding of the disease is largely based on studies involving predominantly White European participants. This review summarizes existing knowledge and data on non-pharmacological interventions exploring the pathophysiology of type 2 diabetes in sub-Saharan Africa, while also highlighting factors that may influence its pathogenesis.
Article
Medicine, General & Internal
Steven B. Heymsfield, Laura A. Coleman, Ram Miller, Daniel S. Rooks, Didier Laurent, Olivier Petricoul, Jens Praestgaard, Therese Swan, Thomas Wade, Robert G. Perry, Bret H. Goodpaster, Ronenn Roubenoff
Summary: The study showed that blockade of the ActRII pathway with bimagrumab led to significant loss of fat mass, gain in lean mass, and metabolic improvements over 48 weeks in patients with type 2 diabetes and overweight or obesity. Inhibition of ActRII pathway may offer a novel approach for managing excess adiposity and metabolic disturbances.
Article
Endocrinology & Metabolism
Shihao Hu, Yuzhi Lu, Andrea Tura, Giovanni Pacini, David Z. D'Argenio
Summary: Glucose effectiveness, the ability of glucose to regulate glucose utilization and production in the body, plays a significant role in maintaining normal blood sugar levels. Hierarchical statistical analysis revealed that individuals with type 2 diabetes had a decreased glucose effectiveness compared to non-diabetic individuals. This finding suggests that glucose effectiveness could be a potential marker for glucose metabolism disorders and a target for diabetes treatment.
FRONTIERS IN ENDOCRINOLOGY
(2021)
Article
Chemistry, Multidisciplinary
Zhibin Zhang, Dongtao Zhou, Xiaowei Luan, Xuyuan Wang, Zhenxing Zhu, Wen Luo, Jingjing Yang, Shaochun Tang, Yujun Song
Summary: Liver-targeted biodegradable nanoshells are designed to restore liver function and improve insulin resistance by reducing oxidative stress, providing a promising approach for treating type 2 diabetes.
Review
Medicine, General & Internal
Ehtasham Ahmad, Soo Lim, Roberta Lamptey, David R. Webb, Melanie J. Davies
Summary: Type 2 diabetes accounts for nearly 90% of global diabetes cases, with an increasing number of affected individuals, particularly among young people. Early detection and proactive management are crucial for preventing complications and reducing mortality. Technology and precision medicine offer potential improvements to treatment outcomes but face significant barriers.
Editorial Material
Biochemistry & Molecular Biology
Roy W. Beck
Summary: Automated insulin delivery systems, used in type 1 diabetes, hold promise for patients with type 2 diabetes and are expected to have a significant impact on public health.
Article
Rehabilitation
Richard Crevenna, Franz Kainberger, Christoph Wiltschke, Christine Marosi, Michael Wolzt, Fadime Cenik, Mohammad Keilani
DISABILITY AND REHABILITATION
(2020)
Article
Cardiac & Cardiovascular Systems
Guenter Stix, Michael Wolzt, Hans Domanovits, Pavla Kadlecova, Bernhard Husch, Michaela Trebs, Juri Hodisch, Martin Unger, Guenther Krumpl
CIRCULATION JOURNAL
(2020)
Article
Radiology, Nuclear Medicine & Medical Imaging
Fabian Niess, Albrecht Ingo Schmid, Wolfgang Bogner, Michael Wolzt, Pierre Carlier, Siegfried Trattnig, Ewald Moser, Martin Meyerspeer
MAGNETIC RESONANCE IN MEDICINE
(2020)
Article
Pharmacology & Pharmacy
Stefan Weisshaar, Laura Brandt, Brigitte Litschauer, Safoura Sheik-Rezaei, Laura Moser, Guenther Nirnberger, Elisabeth Kuehberger, Ulrike Bauer, Christa Firbas, Ghazaleh Gouya, Michael Wolzt, Gabriele Fischer
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
(2020)
Article
Medicine, General & Internal
Stefan Traussnigg, Emina Halilbasic, Harald Hofer, Petra Munda, Tatjana Stojakovic, Guenter Fauler, Karl Kashofer, Martin Krssak, Michael Wolzt, Michael Trauner
Summary: In non-diabetic NAFLD patients, the non-steroidal FXR agonist PX-104 improved insulin sensitivity and liver enzymes after 4 weeks of treatment. While hepatic steatosis and other measures did not change, alterations in fecal BAs and gut microbiota warrant further investigation.
WIENER KLINISCHE WOCHENSCHRIFT
(2021)
Article
Pharmacology & Pharmacy
Ludwig Traby, Marietta Kollars, Alexandra Kaider, Jolanta Maria Siller-Matula, Oskar Steinbrecher, Michael Wolzt, Paul Alexander Kyrle, Sabine Eichinger
Summary: Both DAPT and SAPT have similar effects on platelet and coagulation activation in venous blood.
CLINICAL PHARMACOLOGY & THERAPEUTICS
(2021)
Article
Chemistry, Applied
Astrid Pany, Marie Wohlgenannt, Safoura Klopprogge, Michael Wolzt, Thomas Heuser, Harald Kotisch, Claudia Valenta, Victoria Klang
Summary: The study evaluated the effect of HP-beta-CD in cosmetic submicron emulsions and emulsion gels on physiological skin parameters during regular application. The results showed that both submicron emulsions and gels had satisfactory storage stability and good skin tolerability, without significant effects on skin barrier function.
INTERNATIONAL JOURNAL OF COSMETIC SCIENCE
(2021)
Article
Medicine, General & Internal
Rainer Oberbauer, Matthias Edinger, Gabriela Berlakovich, Peter Kalhs, Nina Worel, Georg Heinze, Michael Wolzt, Thomas Lion, Thomas Wekerle
Summary: This study aims to investigate whether treatment with recipient Tregs and donor BM can lead to transient chimerism in kidney transplant recipients, potentially offering a new therapeutic option for immunomodulation in organ transplantation.
FRONTIERS IN MEDICINE
(2021)
Article
Geriatrics & Gerontology
Safoura Sheikh Rezaei, Hana Sinkovec, Alexander Schoeberl, Christoph Rinner, Georg Heinze, Michael Wolzt, Walter Gall
Summary: This study aimed to estimate the utilization of PIM and incidence of ADE in older adults with CKD. The research found that despite the high utilization of PIM, only a small number of these drugs eventually led to hospitalization due to ADE, suggesting an assessment of potential ADE severity to a PIM list is prudent.
Article
Multidisciplinary Sciences
Stefan Wampl, Tito Koerner, Ladislav Valkovic, Siegfried Trattnig, Michael Wolzt, Martin Meyerspeer, Albrecht Ingo Schmid
Summary: The study investigated the impact of heart geometry and metabolic activity variations over the cardiac cycle on P-31 MRS data quality and metabolite ratios. By triggering acquisitions to end-systole, improved signal amplitudes and fit quality were observed. The study concluded that triggering to end-systole is superior to triggering to diastasis.
SCIENTIFIC REPORTS
(2021)
Article
Pharmacology & Pharmacy
Claudia Vater, Alexandra Apanovic, Christoph Riethmuller, Brigitte Litschauer, Michael Wolzt, Claudia Valenta, Victoria Klang
Summary: The study evaluated the effects of pure lecithins compared to conventional surfactants on skin, with results indicating better skin tolerability with lecithin-based surfactants and encouraging further investigation.
Article
Medicine, General & Internal
Thomas Perkmann, Nicole Perkmann-Nagele, Thomas Koller, Patrick Mucher, Astrid Radakovics, Michael Wolzt, Oswald F. Wagner, Christoph J. Binder, Helmuth Haslacher
Summary: Individuals with previous SARS-CoV-2 infection showed significantly higher antibody response after receiving the first dose of the Pfizer vaccine compared to those who were naive to the virus. This suggests the need for further research on whether individuals with prior infection would benefit from a two-dose vaccination schedule or if the second doses could be saved for others in need.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
(2021)
Article
Public, Environmental & Occupational Health
Jasmina Preinreich, Safoura Sheikh Rezaei, Martina Mittlboeck, Stefan Greisenegger, Berthold Reichardt, Michael Wolzt
Summary: In Austria, NOAC treatment is associated with a lower risk of stroke recurrence compared to VKA, but with increased mortality. The study found that diabetes, cardiovascular disease, and age are significant factors influencing stroke recurrence or death.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
(2021)
Article
Multidisciplinary Sciences
Karolina Samekova, Christa Firbas, Johanna Irrgeher, Christine Opper, Thomas Prohaska, Anika Retzmann, Cornelius Tschegg, Claudia Meisslitzer, Anastassiya Tchaikovsky, Ghazaleh Gouya, Michael Freissmuth, Michael Wolzt
Summary: Oral intake of purified clinoptilolite tuff can reduce enteral uptake of Pb-204 in healthy humans by approximately 90%, leading to a decrease in lead toxicity.
SCIENTIFIC REPORTS
(2021)
Article
Clinical Neurology
Janine Kutzsche, Dagmar Jurgens, Antje Willuweit, Knut Adermann, Carola Fuchs, Stefanie Simons, Manfred Windisch, Michael Humpel, Wolfgang Rossberg, Michael Wolzt, Dieter Willbold
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS
(2020)